JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances tantitumor function in a Fas/FasL signal-independent pathway
Yang Liu,1 Yue-ru Wang,2 Guang-hui Ding,1 Ting-song Yang,1 Le Yao,1 Jie Hua,1 Zhi-gang He,1 Ming-ping Qian1 1Department of Hepatobiliary Surgery, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of China; 2Department of Infectio...
Main Authors: | Liu Y, Wang YR, Ding GH, Yang TS, Yao L, Hua J, He ZG, Qian MP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/jak2-inhibitor-combined-with-dc-activated-afp-specific-t-cells-enhance-peer-reviewed-article-OTT |
Similar Items
-
Leucemia mielóide crônica e o sistema Fas-FasL Chronic myeloid leukemia and the Fas-FasL system
by: Ana Paula F. Bergantini, et al.
Published: (2005-06-01) -
The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms
by: Spasovski Vesna, et al.
Published: (2010-01-01) -
Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
by: Giovanna Flores-Mendoza, et al.
Published: (2021-03-01) -
Correlation between Fas and FasL proteins expression in normal gastric mucosa and gastric cancer
by: Jolanta Czyżewska, et al.
Published: (2011-04-01) -
Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis
by: A. Berdeli, et al.
Published: (2012-12-01)